Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Zexie Decoction is a Traditional Chinese Medicine (TCM) herbal formula derived from the classic Zexie Tang (Alisma Decoction). It is being investigated by The Second Affiliated Hospital of Guangzhou University of Chinese Medicine for the treatment of postmenopausal metabolic syndrome. The formula typically centers on *Alisma plantago-aquatica* (Zexie) and *Atractylodes macrocephala* (Baizhu), modified with additional herbs to target the complex pathophysiology of metabolic syndrome, including dyslipidemia, hypertension, and insulin resistance. In clinical studies, it is administered as either traditional decoction pieces or as modern formula granules to evaluate efficacy, safety, and consistency between these two delivery formats.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Zexie Decoction (Guangdong Provincial Hospital of Traditional Chinese Medicine).